Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 801–850 of 1,812 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04988191	Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer	unknown	Phase 1 / Phase 2	44	Peking UniversityOTHER	1	Aug 3, 2021	clinicaltrials
NCT04984434	Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma	unknown	Phase 1	68	Shandong New Time Pharmaceutical Co., LTDINDUSTRY	1	Jul 30, 2021	clinicaltrials